About: covid:1b8b01823f680cc2d9c0c66a58ba940afa42763a

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:1b8b01823f680cc2d9c0c66a58ba940afa42763a Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Greene, Tom Grissom, Colin Webb, Brandon Do, Brown, Samuel Buckel, Whitney Harris, Estelle Iii, Robert Johnson, Stacy Leither, Lindsay Mph, M Peltan, Ithan Srivastava, Raj Starr, Nathan Kumar Mph, Naresh
is schema:about of	named entity 'viral replication' named entity 'enters' named entity 'In vitro' named entity 'anti-viral' named entity 'observed' named entity 'interferes' named entity 'comparator' named entity 'anti-viral' named entity 'Chloroquine' named entity 'Azithromycin' named entity 'COVID-19' named entity 'meta-analyses' named entity 'DSMB' named entity 'cumulative distribution functions' named entity 'influenza' named entity 'DSMB' named entity 'COVID' named entity 'rifapentine' named entity 'antacids' named entity 'COVID' named entity 'cimetidine' named entity 'REDCAP' named entity 'MERS' named entity 'azithromycin' named entity 'hydroxychloroquine' named entity 'DSMB' named entity 'HIPAA' named entity 'REDCAP' named entity 'Research staff' named entity 'case series' named entity 'hydroxychloroquine' named entity 'dofetilide' named entity 'videophone' named entity 'informed consent' named entity 'hydroxychloroquine' named entity 'rifampicin' named entity 'incubation period' named entity 'posterior probability' named entity 'COVID-19' named entity 'standard deviation' named entity 'clinical practice' named entity 'FDA' named entity 'interleukin-6' named entity 'TNF' named entity 'COVID-19' named entity 'research staff' named entity 'odds ratios' named entity 'odds ratio' named entity 'ordinal scale' named entity 'tumor necrosis factor' named entity 'hydroxychloroquine' named entity 'agnostic' named entity 'ICU' named entity 'clinical pharmacists' named entity 'hydroxychloroquine' named entity 'clinical trials' named entity 'survivorship bias' named entity 'COVID' named entity 'phenobarbital' named entity '2.0' named entity 'azithromycin' named entity 'COVID-19' named entity 'proportional odds model' named entity 'informed consent' named entity 'DSMB' named entity 'COVID-19 pandemic' named entity 'flecainide' named entity 'consent form' named entity 'Utah' named entity 'Research staff' named entity 'Chikungunya virus' named entity 'Hydroxychloroquine' named entity 'hydroxychloroquine' named entity 'COVID' named entity 'OCR' named entity 'case series' named entity 'prior distribution' named entity 'odds ratio' named entity 'Bayesian analysis' named entity 'viral replication' named entity 'ACE2 receptor' named entity 'consent form' named entity 'betacoronavirus' named entity 'HIV' named entity 'odds ratio'

Attributes

Values

Creator

Greene, Tom
Grissom, Colin
Webb, Brandon
Do,
Brown, Samuel
Buckel, Whitney
Harris, Estelle
Iii, Robert
Johnson, Stacy
Leither, Lindsay
Mph, M
Peltan, Ithan
Srivastava, Raj
Starr, Nathan
Kumar Mph, Naresh

is schema:about of

named entity 'viral replication'
named entity 'enters'
named entity 'In vitro'
named entity 'anti-viral'
named entity 'observed'
named entity 'interferes'
named entity 'comparator'
named entity 'anti-viral'
named entity 'Chloroquine'
named entity 'Azithromycin'
named entity 'COVID-19'
named entity 'meta-analyses'
named entity 'DSMB'
named entity 'cumulative distribution functions'
named entity 'influenza'
named entity 'DSMB'
named entity 'COVID'
named entity 'rifapentine'
named entity 'antacids'
named entity 'COVID'
named entity 'cimetidine'
named entity 'REDCAP'
named entity 'MERS'
named entity 'azithromycin'
named entity 'hydroxychloroquine'
named entity 'DSMB'
named entity 'HIPAA'
named entity 'REDCAP'
named entity 'Research staff'
named entity 'case series'
named entity 'hydroxychloroquine'
named entity 'dofetilide'
named entity 'videophone'
named entity 'informed consent'
named entity 'hydroxychloroquine'
named entity 'rifampicin'
named entity 'incubation period'
named entity 'posterior probability'
named entity 'COVID-19'
named entity 'standard deviation'
named entity 'clinical practice'
named entity 'FDA'
named entity 'interleukin-6'
named entity 'TNF'
named entity 'COVID-19'
named entity 'research staff'
named entity 'odds ratios'
named entity 'odds ratio'
named entity 'ordinal scale'
named entity 'tumor necrosis factor'
named entity 'hydroxychloroquine'
named entity 'agnostic'
named entity 'ICU'
named entity 'clinical pharmacists'
named entity 'hydroxychloroquine'
named entity 'clinical trials'
named entity 'survivorship bias'
named entity 'COVID'
named entity 'phenobarbital'
named entity '2.0'
named entity 'azithromycin'
named entity 'COVID-19'
named entity 'proportional odds model'
named entity 'informed consent'
named entity 'DSMB'
named entity 'COVID-19 pandemic'
named entity 'flecainide'
named entity 'consent form'
named entity 'Utah'
named entity 'Research staff'
named entity 'Chikungunya virus'
named entity 'Hydroxychloroquine'
named entity 'hydroxychloroquine'
named entity 'COVID'
named entity 'OCR'
named entity 'case series'
named entity 'prior distribution'
named entity 'odds ratio'
named entity 'Bayesian analysis'
named entity 'viral replication'
named entity 'ACE2 receptor'
named entity 'consent form'
named entity 'betacoronavirus'
named entity 'HIV'
named entity 'odds ratio'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software